Endocrine Tumours Flashcards

1
Q

What’s the distribution of canine pituitary adenoma, invasive adenoma, and adenocarcinoma on necropsy?

A

61% = adenoma
33% = invasive adenoma
6% = adenocarcioma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What % of dogs will not have a visible pituitary mass on CT or MRI when they are first diagnosed with PDH?

A

40-50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What % of dogs will have a visible pituitary mass on CT or MRI when they are first diagnosed with PDH?

A

15-25%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Are there any commercially available diagnostic tests that can predict a PDH patient’s risk at developing neurological signs in dogs?

A

No.
The pro-opiomelanocortin/pro-ACTH levels are correlated to pituitary gland size in dogs with PDH but this is not commercially available

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What’s the MOA of trilostane?

A

It’s a corticosteroid analog that inhibits 3-beta-hydroxysteroid –> essential for the production of cortisol and other steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What’s the MOA of pasireotide?

A

It’s a somatostatin receptor analog that has shown some efficacy in decreasing the pituitary tumour volume, improving ACTH concentration, urine creatinine:cortisol, and clinical signs
- AE: diabetes mellitus
- very expensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What medications that can improve the “dopamine tone” has been used for canine PDH with some efficacy?

A
  • selegiline
  • cabergoline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What pituitary height to brain ratio would be considered to have a pituitary macroadenoma in dogs?

A

> 0.31

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What’s the outcome of transsphenoidal hypophysectomy for dogs with pituitary tumours?

A
  • periop survival = 91%
  • MST = 781 days (~2y)
  • median DFI = 951 days (~2.5y)
  • Recurrence rate = 27%
  • median time to recurrence = 555d (~1.5y)
  • will need lifelong thyroid and glucocorticoid supplement, and desmopressin short term or long term
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What’s the outcome reported in a prospective study in dogs with PDH treated with transsphenoidal hypophysectomy?

A

Success rate ~65%
- 12/150 (8%) died post-op
- 127/150 (85%) remission
- 32/150 (21%) recurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some surgical complications of transsphenoidal hypophysectomy in dogs?

A
  • hemorrhage
  • electrolyte imbalance
  • neurological deficits
  • decreased tear production
  • thromboembolic disease
  • recurrent PDH
  • perioperative death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What’s the general outcome of RT for PDH in dogs?

A
  • 2 to 3.8y
  • smaller tumours had better outcome
  • effective at controlling the neurological signs
  • variable outcome for the Cushing’s aspect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What % of dogs/ cats will have HAC due to PDH?

A

80-85%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What’s the outcome of transsphenoidal hypophysectomy in cats with PDH?

A

-2/7 (29%) died within 4 weeks of surgery
- 2/7 (29%) died several months after the surgery
- 1/7 (14%) was in remission for 19 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some surgical complications of transsphenoidal hypophysectomy in dogs?

A
  • hypopituitarism (short or long term)
  • electrolyte imbalance
  • soft palate dehiscence
  • reduced tear production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What’s the outcome of RT for feline PDH?

A

unclear how it manages the endocrine disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What’s the medical treatment of choice for feline PDH?

A

trilostane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What’s the likelihood of acromegaly in cats?

A
  • 10-15% of diabetic cats
  • up to 30% of hard-to-control diabetic cats
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What’s mechanism of insulin resistance in cats with acromegaly?

A
  • due to GH-induced post-receptor defect in the action of insulin on target cells
  • these cats keep on gaining weight! (opposite of a typical diabetic cats)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What’s the blood test that can be used to diagnose acromegaly?

A
  • serum insulin-like growth factor 1 (IGF-1)
  • sensitivity = 84%; specificity = 92%
  • there can be some overlap with uncontrolled diabetic cats
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Is serum IGF-1 concentration reflective of diabetic control for feline acromegaly treated with RT?

A

No, serum IGF-1 concentration doesn’t appear to correlate with improved diabetic control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What’s the outcome of surgery for acromegaly?

A
  • only a few published cases
  • 3/21 died post-op
  • remaining 18 had reduction in IGF-1
  • 14 achieved diabetic remission
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What’s the outcome of SRT for feline acromegaly?

A

MST = 1072d (2.9y)
- no association noted between tumor size or serum IGF-1 concentration and survival
- 10 had acute RT side effects –> pred resolved issues
- 7/50 had hypothyroidism months to years post
- 39/41 reduced insulin dose
- 13/41 (32%) went into diabetic remission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are some options for medical therapy for feline acromegaly?

A
  • octreotide –> unsure of long term outcome
  • pasireotide –> encouraging, but expensive and causes diarrhea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What’s the outcome of feline acromegaly treated with insulin only (for the diabetes)?

A

MST = 20.5m
- Patients may succumb to cardiac or renal failure, neurologic disease, or complications of poorly regulated diabetes mellitus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Does mineralization of the adrenal gland indicate malignancy?

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What’s the sensitivity and specificity to detection adrenal tumour invasion into the caudal vena cava based on U/S? CT?

A

U/S:
Sensitivity = 80-100%
Specificity: 90%

CT:
Sensitivity = 92%
Specificity: 100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What’s a general size cut off of canine adrenal glands that would indicate malignancy?

A

> 2cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What’s the metastatic rate of canine adrenocortical carcinoma?

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Where are the most common locations for metastasis for canine adrenocortical carcinoma?

A

liver and lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What’s the likelihood of vascular invasion into phrenicoabdominal vein/ renal vein/ caudal vena cava for canine adrenocortical carcinoma?

A

20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What’s one characteristic of dogs with ADH that is different than those with PDH?

A

The majority of dogs with ADH >20kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What would be diagnostic test of choice for ADH?

A

LDDST,
ACTH stim only has 60% sensitivity for diagnosing ADH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What’s the thickness of the contralateral adrenal gland in dogs to be consistent with ADH?

A

<5mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What’s the outcome of adrenalectomy for canine adrenocortical carcinoma?

A

MST = 230-778d (~0.5-2y)
- adenoma MST - 688d (1.8y)
- can be good if survives the post-op period
- mean ST = 3y
- 29/144 (20%) died during surgery or immediate post-op

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What’s the outcome for canine adrenocortical tumours treated with SRT?

A

in a small case series of 9 dogs:
- 6 = non secretory
MST = 1030d (2.8y)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What are some medical treatment options for ADH?

A

mitotane (cytotoxic) or trilostane
- MST is similar, worse if metastasis is present
- Mitotane: 3.5-15.6m
- Trilostane: 12-15m

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What’s a key feature of aldosterone-secreting adrenal tumour on serum biochem?

A

hypokalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What’s the most common adrenocortical disorder in cats?

A

Hyperaldosteronism (aka primary aldosteronism or Conn’s syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What are some clinical signs of Conn’s syndrome?

A
  • muscle weakness from hypokalemia
  • arterial hypertension/ ocular changes
  • hypernatremia usually not present due to intact water balance mechanism
  • concurrent renal disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What’s one test that has been shown to be useful in diagnosing feline hyperaldosteronism?

A

oral fludrocortisone suppression test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

How is primary aldosteronism treated in cats?

A
  • Surgery if unilateral - has good outcome
  • if no surgery, medical management with potassium supplementation, spironolactone, and antihypertensive drugs can give reasonable ST
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What’s the metastatic rate of pheochromocytoma in dogs?

A

up to 40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

What’s the rate of caudal vena cava invasion in canine pheochromocytoma?

A

up to 82%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What are the most common metastatic sites of pheochromocytoma?

A

liver, spleen, lungs, regional lymph nodes, bones, and CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Which IHC can be used for diagnosing pheochromocytoma?

A

chromogranin-A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Which blood test can be used to diagnose pheochromocytoma?

A

normetanephrine (in urine or blood)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What’s the outcome adrenalectomy for pheochormocytoma?

A

if survive the peri-op period, MST = 374d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

What’s the outcome of SRT for canine pheochromocytoma?

A

5/8 dogs were alive at the time of follow up, with a median follow up time of 25.8 months (>2y)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

What’s the mortality rate of adrenalectomy in dogs?

A

15-37%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

What are some prognostics factors for adrenalectomy in dogs?

A
  • presence/ size of thrombus
  • concurrent nephrectomy
  • blood transfusion
  • tumour type
  • tumour size (>5cm)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

What medical therapy is needed for patients with ADH post adrenalectomy in dogs?

A

supraphysiologic dose of prednisone post-op, tapered off over several weeks
- good to perform TEG and ACTH stim, too

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

What’s the outcome of adrenalectomy in cats?

A
  • MST = 50 weeks (just under a year)
  • 70% survived >2week post-op
  • Laparoscopic: MST = 803d (2.2y)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

What’s the outcome for cats with Conn’s syndrome treated with adrenalectomy?

A

MST = 1297d (3.5y)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

What’s a suggested protocol for monitoring incidentaloma?

A

If the mass is <2cm and there is concurrent endocrine abnormalities, then repeat U/S every 3m
- need to make sure this is not an adrenal met!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

When should adrenalectomy be considered for incidentaloma?

A
  • > 2.5cm
  • locally invasive
  • functional
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

What type of thyroid carcinoma is more common in the dog? what’s the significance?

A
  • Follicular thyroid carcinoma is more common in the dog
  • Medullary thyroid carcinoma is thought to be less metastatic
  • more of a human thing –> this distinction is rarely used clinically
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

How good is U/S for diagnosing thyroid carcinoma?

A
  • it’s a good screening tool
  • but not as good as CT or MRI for determining the invasiveness or thyroid origin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

What are the most common places for thyroid carcinoma to spread to?

A
  • Regional LNs (including the mandibulars!)
  • lungs
  • abdominal organs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

What’s a good way to assess the invasiveness of a thyroid carcinoma?

A

CT scan!
- it’s better than palpation
- if it looks round/ovoid & mobile then likely noninvasive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

What are some potential complications of surgery for thyroid carcinoma?

A
  • hemorrhage
  • damage to the recurrent laryngeal nerve/ laryngeal paralysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Is bilateral thyroid carcinoma worse (in terms of ST) than unilateral thyroid carcinoma?

A
  • the ST after surgery is comparable between total thyroidectomy and unilateral thyroidecotmy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

What medical therapy may be required for dogs undergoing total thyroidecotmy?

A
  • if the parathyroid gland is not preserved, need to monitor for hypocalcemia and supplement as needed
  • not all dogs with post-op hypocalcemia will need long-term supplementation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

What’s the outcome of radiation therapy for invasive thyroid carcinoma in dogs?

A
  • hypofractionated protocol = 96 weeks (1.8y)
  • definitive intent = 24.5m
  • palliative = 170d (6m)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Is pulmonary metastasis a negative prognostic factor for canine thyroid carcinoma treated with RT?

A

no!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

What endocrine abnormalities can occur after RT for canine thyroid carcinoma?

A

hypothyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

What’s the outcome of dogs with invasive thyroid carcinoma treated with I131?

A
  • good!
  • if based on scintigraphy and body (+/- surgery), MST = 30m (2.5y)
  • if based on emprical dosing = 34m (~3y)
  • if using really high dose, fatal bone marrow suppression is possible
  • those with metastasis = 366 d (1y) vs 839 d (2.3y) without metastasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

What’s an advantage of I131 or RT?

A

I131 can also target metastatic disease
(RT is can offer even dose distribution within the tumour)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

What’s the general outcome of dogs with unilateral, mobile, thyroid carcinoma treated with thyroidecotmy?

A
  • good!
    36m (3y)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

What are some features of canine thyroid carcinoma likely means higher risk of metastasis?

A
  • large tumour size (diameter and volume)
  • bilateral
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

What are some features of canine thyroid carcinoma likely means shorter disease free interval?

A

gross and histological evidence of vascular invasion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

What’s the role of chemotherapy for dogs with surgically removed thyroid carcinoma?

A
  • undefined
  • one study did not find improved ST after surgery
  • carboplatin is the chemo choice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

What’s the outcome of canine metastatic thyroid carcinoma treated with Palladia?

A
  • 12/15 dogs had a benefit: 4 PR and 8 SD
    (wasn’t used as first line treatment)
  • can be considered for metastatic disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

What are some medical management options for canine thyroid carcinoma that Sx, RT or I131 can’t be done?

A
  • methimazole
  • iodine-restricted diet
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

What’s the thyroid status of dogs with thyroid carcinoma?

A
  • 50‐60% of affected dogs are euthyroid
  • 30‐40% are hypothyroid,
  • 10‐20% are hyperthyroid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

What’s the metastatic rate of canine thyroid carcinoma on presentation?

A

8-16‐38%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

How common in bilateral thyroid carcinoma in dogs?

A

9%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

What’s the most common thyroid tumour associated with hyperthyroidism in cats?

A
  • thyroid adenoma
  • malignant thyroid carcinoma only in 1-3% of cats with hyperthyroidism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

How common is bilateral involvement in feline thyroid adnoma?

A

70-90% of cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

How common is metastasis on presentation for feline thyroid carcinoma and what’s the most common metastatic sites?

A
  • 70%
  • regional LNs and lungs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

What’s the most likely environmental contributor t0 (increase) in feline hyperthyroidism?

A
  • consumption of canned cat food
  • many others are reported, but inconsistent/ contradictory
  • ex: iodine content of cat food, indoor residence, use of cat litter, exposure to brominated flame retardants, and use of flea-control products
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

How is hyperthyroidism diagnosed in cats?

A
  • elevated tT4
  • if clinical signs present but tT4 is normal/ high normal, can follow up with free T4
  • fT4 should never be used alone as cats with nonthyroid illness can have elevated fT4
  • suppression tests (T3) or stimulation test (TSH, TRH), or scintigraphy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Can scintigraphy distinguish between malignant and benign thyroid tumours in cats?

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

What’s the most common medical therapy for feline hyperthyroidism?

A

Methimazole (carbimazole in Europe, which is converted to methimazole in the body)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

How often to cats experience adverse effects to methimazole/ carbimazole? What are those signs?

A

10-25%
- GI (anorexia, vomiting, diarrhea) –> can try dermal formulation instead, but usually self limiting
- facial excoriation
- hepatotoxicity
- bleeding diatheses
- bloody diathesis (esp in the 1st 3 months)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

What’s a potential long term disadvantage of medical therapy for feline hyperthyroidism?

A

Methimazole/ carbimazole are not cytotoxic. The nodules will continue to grow and it will become more difficult to control, and may be less responsive to I131.

87
Q

What dietary management is available for hyperthyroid cats? what’s a potential disadvantage?

A

Hills y/d –> ultra low iodine diet.
- cat will need to be fed on it exclusively, even a small amount of treats, flavored meds can negate its benefits
- also no cytotoxic, no long-term study on the theoretical concerns of increased malignancy overtime
- not sure how this will affect I131

88
Q

What are some definitive treatment options for feline hyperthyroidisim?

A

Surgery (extracapsular or intracapsular)
I 131 radiotherapy

89
Q

What should be done prior to surgery for feline hyperthyroidism to determine the surgical dose?

A

Scintigraphy need to be performed to determine if it’s unilateral vs bilateral
(patient also need to be stabilized prior to GA, with meds and Beta-adrenergic blockers)

90
Q

What’s the most common intra-op complications for feline hyperthyroidism?

A

cardiac dysrhythmia

91
Q

What’s the most common post-op complication of feline hyperthyroidism?

A

6-15% will have hypocalcemia
(Horner’s and laryngeal paralysis = rare)

92
Q

What’s the outcome of cats with thyroid carcinoma undergoing thyroidectomy?

A

Initially good with resolution of clinical signs, but may remain hyperthyroid or develop recurrent hyperthyroidism within a few months after surgery

93
Q

What are some indications of I131?

A
  • it’s is definitive treatment for feline hyperthyroidism
  • thyroid carcinoma
  • ectopic hyperplastic thyroid tissue
  • bilateral thyroid hyperplasia
94
Q

What’s the MOA of I131?

A

Radioactive iodine emits beta and gamma radiation
- beta irradiation accounts for 80% of the tissue damage
- only travels max 2mm in tissue –> good for local destruction

95
Q

What’s the outcome of I131?

A
  • <5% will have persistent or recurrence of hyperthyroidism
    MST = 2-4y
    most common cause of death/ euthanasia = cancer or renal disease
96
Q

What’s one potential complication of I131 treatment?

A

Hypothyroidism
ST is significant less for cats who develop hypothyroidism with azotemia (compared to nonazotemic cats)

97
Q

What are some risk factors for developing hypothyroidism post I131?

A

maybe a higher dose (4mCi vs 2mCi)

98
Q

What’s the dose of I131 for thyroid carcinoma in cats?

A

20-30mCi (that’s >10x the typical dose!)

99
Q

How can cats with thyroid carcinoma be more effectively treated with I131?

A

Have a combination of surgery followed by I131 –> remove the thyroid cysts

100
Q

What are some alternative treatments for feline hyperthyroidism?

A
  • U/S guided ethanol ablation –> ok for unilateral, not to be used with bilateral disease
  • solitary adenoma can have good response –> resolution of c/s >12m
  • U/S guided percutaneous heat ablation –> not effective long term
101
Q

How does the development of azotemia influence ST for hyperthyroid cats treated with I131?

A
  • one study didn’t show a significant decrease in ST
  • but this is the same group that found the ST to be shorter if the cat becomes hypothyroid and azotemic
102
Q

How common is parathyroid tumours in dogs and cats?

A

uncommon in dogs
rare in cats

103
Q

What’s the most likely tumour type for primary hyperparathyroidism?

A

90% of cats/ dogs will have solitary mass –>
adenoma
- metastasis = extremely rare
- if there are 4 hyperplastic masses –> need to look for secondary hyperparathyroidism

104
Q

What’s the main function of the parathyroid gland?

A

Calcium metabolism through parathyroid hormone (PTH)
- increases Ca2+ from bones, kidneys and intestines, mediated by vitamin D

105
Q

Which breed is predisposed to primary parathyroidism?

A

keeshond dog
- autosomal dominant fashion, causative gene not identified

106
Q

What’s the most common c/s for dogs with hyperparathyrodism?

A

lower urinary tract issues
- urolithiasis or UTI

107
Q

What are some clinical signs of hypercalcemia?

A
  • PU/PD
  • decreased appetite/ anorexia
  • weakness, lethargy
  • weight loss
  • muscle wasting
  • trembling
  • vomiting
108
Q

Would the parathyroid gland be palpable with hyperparathyroidism?

A
  • reported in some cats
  • extremely rare finding in dogs
109
Q

How often is PTH normal for dogs with hypercalcemia?

110
Q

What could be a differentiating factor on serum biochemistry for primary parathyroidism induced hypercalcemia vs vitamin D or renal failure?

A

phosphorus!
In primary hyperparathyroidism, the phosphorus level should be low, but it would be high with vitamin D toxicosis and renal failure

111
Q

Which imaging modality is commonly used for detecting parathyroid nodules?

A

ultrasound

112
Q

What’s the risk of AKI in patients with primary hyperparathyroidism?

A

low!
- 95% of dogs will have BUN and creatinine WNL
- most of the time the increase in calcium takes time to progress and patients are not presented on emergency

113
Q

What biochem value would indicate an increased risk of mineralization for a patient with hypercalcemia?

A

phosphorus x calcium > 70

114
Q

What’s the cause of PU/PD in primary hyperparathyroidism?

A

secondary nephrogenic diabetes insipidus (kidneys become resistant to the effects of ADH)

115
Q

What’s the definitive therapy for primary hyperparathyroidism?

116
Q

How many lobes are there for a normal parathyroid?

A

4 –> 2 internal and 2 external
- 2 are in close proximity to the thyroid gland
- they are small, disc shaped, distinct from the thyroid glands

117
Q

How should post-op hypocalcemia be treated?

A
  • Calcium level should be measured twice daily for 5-7d post-op
  • if total Ca is < 8-9 mg/dL or Ca2+ is < 0.8-0.9 mmol/L
  • or if there are signs of tetany
  • use IV calcium salt for acute setting (No SQ)
  • Calcium or vitamin D PO can be used in subacute/ chronic setting
118
Q

How is hypoparathyroidism treated?

A

1,25-dihydroxyvitamin D3 (Calcitriol)
- rapid onset and short-acting
- use oral vitamin D instead of oral calcium supplement to avoid risk of hypercalcemia

119
Q

How does the pre-op calcium level influence the risk of post-op hypocalcemia?

A

one study found a the higher the calcium level pre-op, the lower the post-op calcium level.
- other studies did not find correlation between pre-op calcium and PTH level and post-op hypocalcemia

120
Q

What’s hungry bone syndrome?

A

When the bones are so aggressively, unregulated taking up calcium that calcium supplementation fails to improve serum calcium level

121
Q

What should be the goal of the calcium level post-op?

A

barely below the normal level, rather than WNL to avoid hypercalcemia

122
Q

What are the reasons for persistent hypercalcemia after surgical removal of a parathyroid gland?

A
  • nodule in another gland
  • ectopic hyperplastic or neoplastic parathyroid nodule
  • can use imaging to find, but since it’s small so can be difficult
123
Q

What’s the % of calcium control after surgery vs ethanol ablation vs radiofrequency ablation?

A

Surgery = 94%
Ethanol = 72%
RFA = 90%

124
Q

What’s the prognosis of primary hyperparathyroidism treated with surgery or ablation techniques?

A
  • very good!
  • metastasis = very rare
  • hypocalcemia can be medically managed
  • even if it’s a carcinoma, both tumour control and resolution of hyperparathyroidism = excellent
125
Q

What’s the % of patients that will have recurrent hypercalcemia after definitive therapy?

A

10%
- and do a 2nd course of therapy

126
Q

What’s the short-term outcome if hyperparathyroidism is not treated with surgery or ablative techniques?

A

Fine
- the disease is slowly progressive
- mild clinical signs
- low risk of kidney failure

127
Q

How common is pancreatic beta-cell tumours in the dog and the cat?

A

rare in cats, uncommon in dogs

128
Q

What’s the hallmark bloodwork changes for insulinoma?

A

low glucose level with normal to high insulin

129
Q

What hormones are produced by insulinoma?

A

insulin!
but also:
- glucagon
- somatostatin
- pancreatic polypeptide
- growth hormone
- IGF-1
- gastrin

130
Q

How aggressive pancreatic beta-cell tumour in people?

A

90% of insulinoma in people are benign
- 5-10% are associated with MEN-1

131
Q

How aggressive is insulinoma in dogs?

A

Mostly malignant
- but malignancy does not consistently reflect behaviour

132
Q

How common is metastasis in canine insulinoma?

133
Q

What are the most common metastatic sites of canine insulinoma?

A
  • regional lymph nodes and liver = most common
  • lungs = rare in dogs
134
Q

What’s the WHO staging system for insulinoma?

A

Stage 1: T1N0M0
Stage 2: T1N1M0
Stage 3: T1N1M1

135
Q

What difference in gene expression is noted between the low-metastatic and high-metastatic insulinoma

A
  • Down regulation of acinar enzymes
  • DNA and cell repair pathways
136
Q

What are some histologically prognostic factors for canine insulinoma?

A
  • Ki67
  • tumour size
  • TNM stage
  • presence of necrosis
  • cellular atypia
  • stromal fibrosis
137
Q

What’s neuroglycopenia?

A

the effect of hypoglycemia on the nervous system

138
Q

What are some signs of hypoglycemia?

A
  • faint/ collapse
  • weakness/ ataxia
  • disorientation
  • change in behaviour
  • seizure
139
Q

What’s the pathophysiology of muscle tremors with hypoglycemia?

A
  • catecholamine in released in response to hypoglycemia
  • also have shaking, anxiety, and hunger
140
Q

How is insulinoma diagnosed?

A

hypoglycemia (<60mg/dL/ 3.3mmol/L) with normal or high insulin.
- Insulin/glucose ratio is not accurate
- glycosylated hemoglobin is usually low with hypoglycemia, but it’s not pathognomonic for insulinoma

141
Q

How good is u/s at diagnosing canine insulinoma?

A
  • can only clearly identify and localize a mass in < 50% of cases
  • also low sensitivity and specificity for detection of metastasis
142
Q

Which imaging modality is more sensitive technique for identifying canine insulinoma: U/S, CT, or SPECT?

A

CT! (10/14)
- but also found a significant number of false positive metastases
- triple phase CT (esp late arterial phase) is pretty good
- SPECT sensitivity = 50%

143
Q

How is canine insulinoma treated?

A

Definitive tx = surgery
- most tumours can be visualized or are palpable in surgery

144
Q

Where is canine insulinoma most likely located?

A

can be found in equal frequency between the left and right limbs

145
Q

What are some post-op complications of canine insulinoma removal?

A
  • need to monitor the glucose level
  • can have transient to long-term hyperglycemia
  • pancreatitis
146
Q

Which chemotherapy is used for treating canine insulinoma?

A

Streptozocin
- cytotoxic
- side effects include: hypoglycemia, diabetes mellitus, vomiting (during infusion), increased liver enzymes, mild hematological changes
- historically nephrotoxicity = DLT, but with aggressive saline diuresis, it’s ok
- can control tumour growth, but glycemic control may be no better than other medical treatments

147
Q

What’s the MOA of prednisone for treating canine insulinoma?

A
  • antagonizes insulin
  • gluconeogenic
  • glycogenolytic
148
Q

What’s the MOA of diazoxide for treating canine insulinoma?

A
  • not cytotoxic
  • suppresses insulin release from beta cells
  • stimulates hepatic gluconeogenesis and glycogenolysis
  • inhibits cellular uptake of glucose
149
Q

What are the side effects diazoxide?

A

uncommon
- ptyalism
- vomiting
- anorexia
- diarrhea
- expensive!!!

150
Q

What’s the MOA of octreotide in treatment of canine insulinoma?

A
  • somatostatin receptor ligand
  • inhibits the synthesis and secretion of insulin by pancreatic beta cells
    (also expensive)
151
Q

What’s the outcome of canine insulinoma with partial pancreatectomy?

A

good!
MST: 12-14m; more recent ~2y (DFI of 1.3y)
- if followed with prednisone, MST = 1316d reported (~3.5y)
- also stage dependent
- Stage III MST < 6m

152
Q

How is the glycemic control after partial pancreatectomy for dogs with insulinoma based on the different stages?

A

Stage 1: 50% will still still be normoglycemia at 14m
Stage II/III: < 20% are free of hypoglycemia at 14m

153
Q

What’s the MST with medical therapy only for canine insulinoma?

A

MST = 452d (1.2y)

154
Q

What’s the outcome of surgery for feline insulinoma?

155
Q

What medical treatment options are available for cats with insulinoma?

A
  • prednisolone
  • diet
  • octreotide
  • no evidence to support the use of diazoxide or streptozocin
156
Q

How common is gastrinoma in dogs and cats?

A

rare in dogs, very rare in cats

157
Q

What’s Zollinger-Ellison syndrome?

A

Triad of non-beta cell neuroendocrine tumour of the pancreas, high gastrin, and GI ulcer

158
Q

How metastatic is gastrinoma and what are the most common sites of metastasis?

A
  • up to 85% of dogs and cats at diagnosis!
  • liver, reginal LNs, spleen, peritoneum, small intestines, omentum or mesentery
159
Q

What are the consequences of hypergastrinemia?

A
  • gastric mucosal hyperplasia
  • gastric acid hypersecretion
160
Q

What are some common clinical signs of gastrinoma?

A

vomiting and weight loss = most common
- melena, abdominal pain, anorexia, regurgitation, hematemesis, hematochezia, and diarrhea can also occur

161
Q

How does H2 and proton pump inhibitors influence gastrin level?

A

the effects of gastrin increase in mild and short-lived
- may not inhibit the diagnosis of a gastrinoma

162
Q

What’s the treatment of choice of gastrinoma?

A

Exploratory laparotomy
- even with metastatic disease, tumour removal can enhance medical therapy

163
Q

What’s the outcome of gastrinoma in dogs and cats?

A

MST 1 week to 26m!

164
Q

What are some medical treatment options for gastrinoima in dogs?

A

octreotide - it was successful in 3 dogs

165
Q

What’s a paraneoplastic syndrome of glucagonoma?

A

necrotizing migratory erythema
- hyperkeratosis, crusting, ulceration, and erosions
- footpads, mucocutaneous junctions, external genitalia, distal extremities, pressure points, and ventral abdomen
DDX: liver disease (more common for NME)

166
Q

What’s the outcome of glucagonoma?

A

poor, highly metastatic
- NME may resolve with surgery or medical therapy

167
Q

What bloodwork changes can be noted with glucagonoma?

A

hyperglycemia
- hypoaminoacidemia
- increased liver enzymes

168
Q

Can glucagonoma be diagnosed on bloodwork?

A

plasma glucagon and amino acid level have been tried, but unknown sensitivity/ specificity

169
Q

What’s the treatment for intestinal carcinoid?

A

Surgery, though metastasis is common on presentation

170
Q

Where can intestinal carcinoids be located?

A

They are from the neuroendocrine cells of the GI system
- liver
- intestines
- gallbladder
- pancreas

171
Q

What’s the prognosis of intestinal carcinoid?

A

poor, metastasis is common

172
Q

Is SRT better than CFRT for canine pituitary tumours?

A

In one retrospective comparison study, the overall MST = 608d (1.6y)
- younger dogs (<9y) MST = 753d (~2y) vs 445d (1.2y)
- ST was not associated with protocol

173
Q

What are some CT features of exocrine pancreatic carcinoma in dogs/ cats?

A
  • well defined mass with contrast enhancement
  • heterogenous
  • more common in R lobe
  • lymphadenopathy (esp with larger masses)
174
Q

What’s the metastatic rate of canine thyroid carcinoma on presentaiton?

A

1/3
- 14-26% for LN mets
- 20-38% pulmonary mets

175
Q

What does the thyroid follicular cells produce? medullary cells produce?

A
  • Follicular cells = colloid, thyroid hormones and thyroglobulins
  • Medullary cells = c-cells = parafollicular cells = calcitonin
176
Q

What IHC markers can be used to distinguish between follicular thyroid, medullary thyroid, and parathyroid tumours?

A
  • Follicular thyroid: thyroglobulin (+), thyroid-transcription factor 1 (+), neuroendocrine markers (-)
  • Medullary thyroid: thyroglobulin (-), thyroid-transcription factor 1 (-), neuroendocrine markers (+), calcitonin (+), calcitonin gene-related peptide (+)
  • Parathyroid: thyroglobulin (-), thyroid-transcription factor 1 (-), neuroendocrine markers (+), parathyroid hormone (+)
177
Q

What’s the outcome of incompletely removed canine thyroid carcinoma without adjuvant therapy?

178
Q

What’s the relationship between gastrin and dogs with primary hyperparathyroidism?

A

27/151 (17.9%) of dogs with PHPT have hypergastrinemia, but this is independent of the presence of GI signs

179
Q

What’s the prognosis of dogs with endocrine/ neuroendocrine tumours that develop bone metastasis?

A

With therapy, >100d
(compared to other tumour types, generally < 30d)

180
Q

What’s the MST of canine thyroid neoplasia that underwent thyroidectomy?

A

MST = 802d (2.2y)
- risk factors for cancer related death: presence of metastasis, non-follicular carcinoma, administration of chemo

181
Q

What’s the outcome of SRT for canine pheochromocytoma?

A

n = 8 (11Gy x 3 daily, or 7Gy x 5 EOD)
- all had resolution of clinical signs
- 5/8 still alive at median follow-up time of 25.8m (just over 2y)
- can resolve caval invasion
- RT AE mostly GI

182
Q

What’s the outcome of Palladia for pheochromocytoma?

A

1 PR, 5 SD

183
Q

Is there a insulin concentration difference in the stage and ST for canine insulinoma?

A

No…
there is no significant differences in insulin concentration between dogs with or without metastasis at diagnosis.

184
Q

Is u/s guided core needle biopsy of thyroid tumours in dogs feasible?

A

yes.. apparently it’s safe

185
Q

Which is more sensitive at diagnosing canine pheochromocytoma - plasma free noremetanephrine or metanephrine?

A

normeteanephrine! 100 % vs 73%
both have specificity of 94%

186
Q

What’s the outcome of cats with insulinoma treated with surgery?

A

Study with 20 cats:
-18/20 had euglycemia or hyperglycemia after surgery
- MST = 863d (2.4y)
- Negative prognostic factors = young age, and low serum glucose level, metastasis, tumour invasion, and shorter time to euglycemia
( Veytsman et al, 2023)

187
Q

How can pre-I131 USG in cats predict the risk of post-RAI azotemia in hyperthyroid cats?

A

if pre treatment USG > 1.035 –> 6.4% developed azotemia vs if pre-treatment USG < 1.035, then the risk is 44%
(Peterson and Rishniw, 2023)

188
Q

What’s the post-op complication rate for unilateral adrenalectomy in dogs? What are some factors that contribute to poor outcome?

A
  • Complication rate = 25%
  • Peri-op mortality associated with: increased surgical time, medical treatment other than pheochromocytoma (that had no effect)
  • Decreased overall ST: pancreatitis, aspiration pneumonia, ureternephrectomy
    (Piegols et al 2023)
189
Q

What’s the outcome of canine pituitary macrodenoma treated with RT?

A
  • there was no significant difference between PDH and non-PDH macroadenoma for MST (590d vs 738d {1.6 vs 2y])
    Rapastella, et al 2023
190
Q

How good is PET-CT with 18-FDG for canine insulinoma staging?

A

Unpredictable tumoural avidity limits the value of (18) F-fluorodeoxyglucose positron emission tomography-CT for staging canine insulinomas.

191
Q

What’s the outcome of cats with hypersomatotropism and DM treated with cabergoline?

A

in 23 cats
- IGF-1 concentration improved in 26%
- DM remission in 35%
(Miceli et al 2022)

192
Q

Should alpha-blockers be used prior to surgery for dogs with pheochromocytoma?

A

53 dogs didn’t have pretreatment with pheochromocytoma and 44 survived to discharge with MST of 3.2y

193
Q

What’s a risk factor of developing post-op hypocalcemia for primary parathyrodism?

A
  • if pre-op hypercalcemia is > or = 1.75mEq/L = 7.5x risk of post-op hypocalcemia
    (Burkhardt, et al 2021)
194
Q

What U/S feature is more consistent with a malignant parathyroid tumour?

A

nodule > or = 8mm
(Burkhardt, et al 2021)

195
Q

How accurate is U/S as pre-op assessment for primary parathyroids in terms of number of nodules affected and laterality compared to surgery?

A
  • # of nodules: 65.9%
  • laterality: 72.3%
196
Q

What’s the outcome of feline hypersomatotropism treated with transsphenoidal hypophysectomy?

A

in 25 cats:
- MST = 1347d (3.7y)
- 23/24 can remission from hypersomatotropism
- 22/24 achieved diabetic remission

197
Q

What are some common clinical signs for dogs with insulinoma?

A

weakness (60%), epileptic seizures (33.6%)
(Ryan et al 2021)

198
Q

What’s the outcome of canine insulinoma treated with surgery?

A

MST = 20m, better than 8m for those treated medically.
- metastasis is the only variable associated with prognosis

199
Q

What’s the detection of canine insulinoma with dual phase CT?

A

found nodules in 33/35 cases (94%)
- hyperattenuating in the arterial phase (21/22)

200
Q

Can I-131 resolve hyperthyroidism due to ectopic thyroid tumours in dogs?

A

yes, 5/5
(Lyssens et al 2021)

201
Q

What factors are associated with increased odds of relapse and decreased ST in dogs with insulinoma treated with surgery?

A
  • post-op hypoglycemia
  • stage
    In this study, the MST was 372d (1y), Stage I = 652d (1.8y) and Stage II/III = 320d (8m)
    (Del Busto et al 2020)
202
Q

What’s the complication rate of FNA of adrenal tumour?

A

1% death
- 3/50 had acute hemorrhage
- 1/50 death due to respiratory distress

203
Q

How does SDMA predict azotemia in hyperthyroid cats treated with I-131?

A
  • An increased SDMA concentration above the reference interval prior to treatment has a high specificity but poor sensitivity for the prediction of post-treatment azotemia
  • there is a discordance with post treatment creatinine and SDMA
204
Q

What’s the outcome of SRT for dogs with thyroid carcinoma?

A

RR = 70%; 4 (20%) CR, 10 (50%) PR, 4 (20%) SD, and 2 (10%) PD
MPFS = 10m
MST = 1y
- metastasis was not a prognostic factor
(Lee et al 2020)
- responders MPFS = 1y vs 3m
- responder MST = 1.2y vs 3m

205
Q

What’s the outcome of dogs with thyroid carcinoma treated with Palladia in naive/ rescue setting?

A

RR = 88.4%; 1 dog (3.8%) experienced a CR, 11 (42.3%) PR, 11 (42.3%) SD
- Naive MST = 563d (1.5y)
- Rescue MST = 1086d (~3y)
- dogs that were asymptomatic actually had shorter ST
(Sheppard-Olivares et al 2020)

206
Q

Is the pretreatment T4 and post treatment T4 correlated in cats treated with a fixed dose of oral RAI?

A

nope!
(Yu et al 2020)

207
Q

What’s the metastatic rate and pattern of canine thyroid carcinoma?

A

18.6% on presentation
- all medial retropharyngeal metastasis were ipsilateral (7/77, 9.1%): there was no contralateral mets
- 14/41 (34%) had metastatic deep cervical LN
- medullary or mixed follicular/medullary tumours (62.8%) were more likely to have metastasis than follicular (8.2%)
- All metastatic LNs are ipsilateral
(Skinner et al 2024)

208
Q

What’s the outcome of adrenalectomy for ruptured adrenal mass?

A
  • good if they survive the periop period
  • short term (<2w) complications were 42% (21% death)
  • MST = 574d (1.6y)
  • MST = 900d (2.5y) if short term death is censored
209
Q

What’s the significance of intra-op glucose level for dogs undergoing surgery for insulinoma?

A
  • completeness of resection is related to the glucose level
  • MDFI = 381d (~1y)
  • MST = 762d (2y)
    (Cogrolls et la 2022)
210
Q

What’s the outcome of dogs with exocrine pancreatic adenocarcinoma treated with Palladia?

A

RR = 75%
MST ~ 90d (3m)
(Musser et al 2021)

211
Q

What’s the outcome of endocrine status for cats with acromegaly treated with SRT?

A
  • median time to max reduction is 399d (~13m)
  • MST = 741d (~2y)
  • single fraction 17Gy
    (Watson-Skaggs et al 2021)
212
Q

What’s the outcome of surgery for dogs with parathyroid tumours?

A
  • MST = 2y
  • 89/96 dogs have the hypercalcemia resolve within 7 days
  • 34% develop hypocalcemia
    (Erickson et al 2021)
213
Q

Can size be used to distinguish between hyperplasia, adenoma, and adenocarcinoma of the parathyroid gland based on ultrasound?

A
  • 3mm seems like a goo cut-off between hyperplasia and neoplasia
  • but there is too much overlap